What is CuraMedix?
CuraMedix is dedicated to advancing patient care through evidence-based, non-surgical medical devices. The company's portfolio includes cutting-edge shockwave therapy and Extracorporeal Magneto-Transduction Therapy (EMTT) devices. These technologies are designed to facilitate faster healing, improve patient outcomes, and enhance satisfaction across various medical applications, including pain management, aesthetic treatments, and wound care. By providing advanced, minimally invasive solutions, CuraMedix empowers healthcare practices to offer superior patient experiences and achieve better clinical results.
How much funding has CuraMedix raised?
CuraMedix has raised a total of $170K across 1 funding round:
Debt
$170K
Debt (2021): $170K with participation from PPP
Key Investors in CuraMedix
PPP
Public-Private Partnership
What's next for CuraMedix?
The recent strategic investment in CuraMedix, occurring within a large-scale late-stage funding environment, signals a pivotal phase for the company's growth and market expansion. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden the company's commercial reach. CuraMedix is poised to solidify its leadership in the non-surgical medical device market, leveraging its innovative technologies to address unmet needs in patient care and establish new benchmarks in therapeutic efficacy and patient comfort.
See full CuraMedix company page
